GSK3B and liver cancer: Considering that activated AKT (Figure 6B and Figure 7B) may also contribute to increased c-MYC stability by suppressing GSK-3β activity [68,69], we hypothesized that c-MYC might contribute to the DEN-induced liver cancer phenotype observed in the Ppp2r5d HE and HO mice.